Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
The Journal of Biological Chemistry
|
October 2, 2021
Loss of TDP-43 in male germ cells causes meiotic failure and impairs fertility in mice
Kaitlyn M Campbell, Yiding Xu, Chintan Patel, et al.
Vaccines
|
September 27, 2025
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia
Suresh R Giri, Akshyaya Chandan Rath, Chitrang J Trivedi, et al.
The Lancet Regional Health. Southeast Asia
|
December 11, 2023
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial
Sanket Shah, Ranjan Kumar Nandy, Shaily S Sethi, et al.
Human Vaccines & Immunotherapeutics
|
August 26, 2025
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants
Sanjay Vasant Mankar, Chintan Patel, Abhishek Chavan, et al.
NPJ Vaccines
|
August 18, 2023
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin<sup>®</sup>)
Chandramani Singh, Savita Verma, Prabhakar Reddy, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
The Journal of Biological Chemistry
|
October 2, 2021
Loss of TDP-43 in male germ cells causes meiotic failure and impairs fertility in mice
Kaitlyn M Campbell, Yiding Xu, Chintan Patel, et al.
Vaccines
|
September 27, 2025
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia
Suresh R Giri, Akshyaya Chandan Rath, Chitrang J Trivedi, et al.
The Lancet Regional Health. Southeast Asia
|
December 11, 2023
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial
Sanket Shah, Ranjan Kumar Nandy, Shaily S Sethi, et al.
Human Vaccines & Immunotherapeutics
|
August 26, 2025
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants
Sanjay Vasant Mankar, Chintan Patel, Abhishek Chavan, et al.
NPJ Vaccines
|
August 18, 2023
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin<sup>®</sup>)
Chandramani Singh, Savita Verma, Prabhakar Reddy, et al.
Page
of 7